HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or AntibodiesKaren Schreiber, Beverley J. Hunt, Karen Breen et al.|Seminars in Thrombosis and Hemostasis|2017Cited by 125
Progressive multiple sclerosis, cognitive function, and quality of lifeHelene Højsgaard Chow, Finn Sellebjerg, Karen Schreiber et al.|Brain and Behavior|2018Cited by 94
The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodiesKaren Schreiber, Beverley J. Hunt, Jacob H. Rand et al.|Lara D. Veeken|2017Cited by 54
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trialKaren Schreiber, Per Soelberg Sørensen, Melinda Magyari et al.|Multiple Sclerosis Journal|2016Cited by 53
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis RegistryÁsta Theódórsdóttir, Zsolt Illés, Birgit Debrabant et al.|Multiple Sclerosis Journal|2021Cited by 21